BRAINTREE, Mass., Jan. 9 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today that Ronald Ryan will retire after nearly eight years as Chief Financial Officer. Mr. Ryan will continue to serve as CFO until a successor is appointed. The firm of Heidrich & Struggles has been retained to lead the search for a new CFO.
Brad Nutter, Haemonetics' CEO, said, "I credit Ron's disciplined leadership for the consistent improvements in Haemonetics' cash flow, profitability and balance sheet. I am pleased that Ron has agreed to remain with us for a period of time after his successor is appointed, to assist in the transition and to lead our global enterprise resource planning (ERP) initiative -- the largest and most significant company-wide, internal initiative Haemonetics has embraced."
Mr. Ryan will remain a member of the Company's Operating Committee until his retirement.
Haemonetics is a global company engaged in the design, manufacture and worldwide marketing of automated blood processing systems. These systems address important medical markets: surgical blood salvage, blood component collection, plasma collection, and blood component safety. To learn more about Haemonetics' products and markets, visit its web site at http://www.haemonetics.com.
CONTACT: Julie Fallon Tel. (781) 356-9517 Alternate Tel. (617) 320-2401 fallon@haemonetics.com
Haemonetics CorporationCONTACT: Julie Fallon of Haemonetics Corporation, +1-781-356-9517, or+1-617-320-2401, fallon@haemonetics.com
Web site: http://www.haemonetics.com//
